Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G3DC
|
|||
| Former ID |
DIB008990
|
|||
| Drug Name |
ASP-1001
|
|||
| Synonyms |
Iodinated contrast agent (nasal spray, allergic rhinitis), Asphelia
Click to Show/Hide
|
|||
| Indication | Allergic rhinitis [ICD-11: CA08.0] | Phase 2/3 | [1] | |
| Company |
Asphelia Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00791102) Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.